CA2529494A1 - Polymeric stent and method of manufacture - Google Patents
Polymeric stent and method of manufacture Download PDFInfo
- Publication number
- CA2529494A1 CA2529494A1 CA002529494A CA2529494A CA2529494A1 CA 2529494 A1 CA2529494 A1 CA 2529494A1 CA 002529494 A CA002529494 A CA 002529494A CA 2529494 A CA2529494 A CA 2529494A CA 2529494 A1 CA2529494 A1 CA 2529494A1
- Authority
- CA
- Canada
- Prior art keywords
- stent
- polymer
- layer
- shape
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 64
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 105
- 229940124597 therapeutic agent Drugs 0.000 claims abstract description 78
- 230000007704 transition Effects 0.000 claims abstract description 15
- 230000008859 change Effects 0.000 claims abstract description 11
- 229920000642 polymer Polymers 0.000 claims description 173
- -1 polyethylene Polymers 0.000 claims description 43
- 229920001432 poly(L-lactide) Polymers 0.000 claims description 31
- 230000009477 glass transition Effects 0.000 claims description 29
- 229940079593 drug Drugs 0.000 claims description 26
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 19
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 19
- 229920006254 polymer film Polymers 0.000 claims description 17
- 239000011118 polyvinyl acetate Substances 0.000 claims description 16
- 229920002689 polyvinyl acetate Polymers 0.000 claims description 15
- 238000007493 shaping process Methods 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 239000004014 plasticizer Substances 0.000 claims description 12
- 238000011282 treatment Methods 0.000 claims description 12
- 239000003146 anticoagulant agent Substances 0.000 claims description 11
- 229920001610 polycaprolactone Polymers 0.000 claims description 10
- 239000004632 polycaprolactone Substances 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 10
- 239000003242 anti bacterial agent Substances 0.000 claims description 9
- 230000001028 anti-proliverative effect Effects 0.000 claims description 9
- 229940030600 antihypertensive agent Drugs 0.000 claims description 9
- 239000002220 antihypertensive agent Substances 0.000 claims description 9
- 229960004676 antithrombotic agent Drugs 0.000 claims description 9
- 239000003443 antiviral agent Substances 0.000 claims description 9
- 229920002635 polyurethane Polymers 0.000 claims description 9
- 239000004814 polyurethane Substances 0.000 claims description 9
- 238000000807 solvent casting Methods 0.000 claims description 9
- 108010001857 Cell Surface Receptors Proteins 0.000 claims description 8
- 229920002302 Nylon 6,6 Polymers 0.000 claims description 8
- 230000001455 anti-clotting effect Effects 0.000 claims description 8
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 8
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 8
- 239000002246 antineoplastic agent Substances 0.000 claims description 8
- 230000003115 biocidal effect Effects 0.000 claims description 8
- 239000003114 blood coagulation factor Substances 0.000 claims description 8
- 238000005266 casting Methods 0.000 claims description 8
- 230000001413 cellular effect Effects 0.000 claims description 8
- 229940127089 cytotoxic agent Drugs 0.000 claims description 8
- 239000005556 hormone Substances 0.000 claims description 8
- 229940088597 hormone Drugs 0.000 claims description 8
- 239000003446 ligand Substances 0.000 claims description 8
- 102000006240 membrane receptors Human genes 0.000 claims description 8
- 108020004707 nucleic acids Proteins 0.000 claims description 8
- 150000007523 nucleic acids Chemical class 0.000 claims description 8
- 102000039446 nucleic acids Human genes 0.000 claims description 8
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 claims description 8
- 239000000622 polydioxanone Substances 0.000 claims description 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 8
- 102000008186 Collagen Human genes 0.000 claims description 7
- 108010035532 Collagen Proteins 0.000 claims description 7
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 7
- 229920002732 Polyanhydride Polymers 0.000 claims description 7
- 239000004698 Polyethylene Substances 0.000 claims description 7
- 229920000331 Polyhydroxybutyrate Polymers 0.000 claims description 7
- 229920002678 cellulose Polymers 0.000 claims description 7
- 239000001913 cellulose Substances 0.000 claims description 7
- 229920001436 collagen Polymers 0.000 claims description 7
- 239000005015 poly(hydroxybutyrate) Substances 0.000 claims description 7
- 229920000573 polyethylene Polymers 0.000 claims description 7
- 229920002643 polyglutamic acid Polymers 0.000 claims description 7
- 238000011321 prophylaxis Methods 0.000 claims description 6
- 239000000758 substrate Substances 0.000 claims description 6
- 229920001691 poly(ether urethane) Polymers 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 238000009792 diffusion process Methods 0.000 claims description 4
- 238000004528 spin coating Methods 0.000 claims description 4
- 230000002051 biphasic effect Effects 0.000 claims description 3
- 230000001419 dependent effect Effects 0.000 claims description 2
- 239000004599 antimicrobial Substances 0.000 claims 7
- 229920001054 Poly(ethylene‐co‐vinyl acetate) Polymers 0.000 claims 5
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims 5
- 239000004743 Polypropylene Substances 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 4
- 229920001982 poly(ester urethane) Polymers 0.000 claims 4
- 229920001155 polypropylene Polymers 0.000 claims 4
- 229920000915 polyvinyl chloride Polymers 0.000 claims 4
- 239000004800 polyvinyl chloride Substances 0.000 claims 4
- 239000000463 material Substances 0.000 abstract description 16
- 238000011065 in-situ storage Methods 0.000 abstract description 2
- 239000010410 layer Substances 0.000 description 145
- 239000010408 film Substances 0.000 description 23
- 229920006125 amorphous polymer Polymers 0.000 description 11
- 238000001125 extrusion Methods 0.000 description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- 230000036760 body temperature Effects 0.000 description 8
- 230000015556 catabolic process Effects 0.000 description 8
- 238000006731 degradation reaction Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 229920000954 Polyglycolide Polymers 0.000 description 7
- 229940075065 polyvinyl acetate Drugs 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- 238000002513 implantation Methods 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 229920000747 poly(lactic acid) Polymers 0.000 description 5
- 208000037803 restenosis Diseases 0.000 description 5
- 229920006126 semicrystalline polymer Polymers 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 4
- 229920006037 cross link polymer Polymers 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 229930012538 Paclitaxel Natural products 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229960001592 paclitaxel Drugs 0.000 description 3
- 229920001308 poly(aminoacid) Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000002356 single layer Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 2
- HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 229960003022 amoxicillin Drugs 0.000 description 2
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 229960002896 clonidine Drugs 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- SGTNSNPWRIOYBX-HHHXNRCGSA-N dexverapamil Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCC[C@@](C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-HHHXNRCGSA-N 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 229940030606 diuretics Drugs 0.000 description 2
- 229960004679 doxorubicin Drugs 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 229960005167 everolimus Drugs 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229960002963 ganciclovir Drugs 0.000 description 2
- IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910001092 metal group alloy Inorganic materials 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910001000 nickel titanium Inorganic materials 0.000 description 2
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 2
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 229960002930 sirolimus Drugs 0.000 description 2
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 2
- 210000000626 ureter Anatomy 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 1
- 229910000619 316 stainless steel Inorganic materials 0.000 description 1
- 206010002329 Aneurysm Diseases 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000034530 PLAA-associated neurodevelopmental disease Diseases 0.000 description 1
- 229920012485 Plasticized Polyvinyl chloride Polymers 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000012668 chain scission Methods 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229910000701 elgiloys (Co-Cr-Ni Alloy) Inorganic materials 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000003446 memory effect Effects 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 231100000065 noncytotoxic Toxicity 0.000 description 1
- 230000002020 noncytotoxic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 239000013047 polymeric layer Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 1
- 229960002855 simvastatin Drugs 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000001631 vena cava inferior Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/88—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0076—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof multilayered, e.g. laminated structures
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
- Y10T156/10—Methods of surface bonding and/or assembly therefor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47888703P | 2003-06-16 | 2003-06-16 | |
| US60/478,887 | 2003-06-16 | ||
| PCT/SG2004/000180 WO2004110315A1 (en) | 2003-06-16 | 2004-06-15 | Polymeric stent and method of manufacture |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2529494A1 true CA2529494A1 (en) | 2004-12-23 |
Family
ID=33551858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002529494A Abandoned CA2529494A1 (en) | 2003-06-16 | 2004-06-15 | Polymeric stent and method of manufacture |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20050021131A1 (pt) |
| EP (1) | EP1633280A4 (pt) |
| JP (1) | JP2006527628A (pt) |
| KR (1) | KR20060028695A (pt) |
| CN (1) | CN100558321C (pt) |
| AU (1) | AU2004246998A1 (pt) |
| BR (1) | BRPI0411548A (pt) |
| CA (1) | CA2529494A1 (pt) |
| WO (1) | WO2004110315A1 (pt) |
Families Citing this family (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7758881B2 (en) * | 2004-06-30 | 2010-07-20 | Advanced Cardiovascular Systems, Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
| US8435550B2 (en) * | 2002-12-16 | 2013-05-07 | Abbot Cardiovascular Systems Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
| AU2004246998A1 (en) * | 2003-06-16 | 2004-12-23 | Nanyang Technological University | Polymeric stent and method of manufacture |
| US8709469B2 (en) | 2004-06-30 | 2014-04-29 | Abbott Cardiovascular Systems Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
| US7931671B2 (en) | 2005-03-11 | 2011-04-26 | Radi Medical Systems Ab | Medical sealing device |
| US20070038290A1 (en) * | 2005-08-15 | 2007-02-15 | Bin Huang | Fiber reinforced composite stents |
| GB0517085D0 (en) | 2005-08-19 | 2005-09-28 | Angiomed Ag | Polymer prosthesis |
| DE102005056532A1 (de) * | 2005-11-28 | 2007-05-31 | Mnemoscience Gmbh | Entfernung von tubulären Gewebestützen |
| US10029034B2 (en) * | 2005-12-15 | 2018-07-24 | CARDINAL HEALTH SWITZERLAND 515 GmbH | Drug-eluting articles with improved drug release profiles |
| US8945598B2 (en) * | 2005-12-29 | 2015-02-03 | Cordis Corporation | Low temperature drying methods for forming drug-containing polymeric compositions |
| US20070156230A1 (en) | 2006-01-04 | 2007-07-05 | Dugan Stephen R | Stents with radiopaque markers |
| US20070162110A1 (en) * | 2006-01-06 | 2007-07-12 | Vipul Bhupendra Dave | Bioabsorbable drug delivery devices |
| US20070160672A1 (en) * | 2006-01-06 | 2007-07-12 | Vipul Bhupendra Dave | Methods of making bioabsorbable drug delivery devices comprised of solvent cast films |
| US20090276036A1 (en) * | 2006-01-23 | 2009-11-05 | Terumo Kabushiki Kaisha | Stent |
| US20070254012A1 (en) * | 2006-04-28 | 2007-11-01 | Ludwig Florian N | Controlled degradation and drug release in stents |
| ATE491417T1 (de) * | 2006-05-12 | 2011-01-15 | Ev3 Inc | Implantat und freisetzungssystem mit mehreren markerverriegelungen |
| US9320837B2 (en) * | 2006-05-12 | 2016-04-26 | CARDINAL HEALTH SWITZERLAND 515 GmbH | Balloon expandable bioabsorbable drug eluting flexible stent |
| EP2020967B1 (en) * | 2006-05-12 | 2020-09-23 | Cardinal Health Switzerland 515 GmbH | Baloon expandable bioabsorbable drug eluting stent |
| US20130331926A1 (en) | 2006-05-26 | 2013-12-12 | Abbott Cardiovascular Systems Inc. | Stents With Radiopaque Markers |
| US20080097620A1 (en) * | 2006-05-26 | 2008-04-24 | Nanyang Technological University | Implantable article, method of forming same and method for reducing thrombogenicity |
| US20070292470A1 (en) * | 2006-06-15 | 2007-12-20 | Medtronic Vascular, Inc. | Implantable Medical Devices and Methods for Making the Same |
| US8535372B1 (en) | 2006-06-16 | 2013-09-17 | Abbott Cardiovascular Systems Inc. | Bioabsorbable stent with prohealing layer |
| US8128688B2 (en) * | 2006-06-27 | 2012-03-06 | Abbott Cardiovascular Systems Inc. | Carbon coating on an implantable device |
| US7823263B2 (en) | 2006-07-11 | 2010-11-02 | Abbott Cardiovascular Systems Inc. | Method of removing stent islands from a stent |
| EP2044140B1 (en) | 2006-07-20 | 2017-05-17 | OrbusNeich Medical, Inc. | Bioabsorbable polymeric composition for a medical device |
| US8016879B2 (en) * | 2006-08-01 | 2011-09-13 | Abbott Cardiovascular Systems Inc. | Drug delivery after biodegradation of the stent scaffolding |
| US9173733B1 (en) | 2006-08-21 | 2015-11-03 | Abbott Cardiovascular Systems Inc. | Tracheobronchial implantable medical device and methods of use |
| CN101631513B (zh) | 2006-10-20 | 2013-06-05 | 奥巴斯尼茨医学公司 | 可生物吸收的聚合物组合物和医疗设备 |
| US7959942B2 (en) | 2006-10-20 | 2011-06-14 | Orbusneich Medical, Inc. | Bioabsorbable medical device with coating |
| US8814930B2 (en) | 2007-01-19 | 2014-08-26 | Elixir Medical Corporation | Biodegradable endoprosthesis and methods for their fabrication |
| US8182890B2 (en) * | 2007-01-19 | 2012-05-22 | Elixir Medical Corporation | Biodegradable endoprostheses and methods for their fabrication |
| EP2134380A2 (en) * | 2007-03-28 | 2009-12-23 | Boston Scientific Scimed, Inc. | Medical devices having bioerodable layers for the release of therapeutic agents |
| WO2008152465A2 (fr) * | 2007-06-12 | 2008-12-18 | Bioring Sa | Dispositif biodégradable pour angioplastie temporaire et induction réparatrice des conduits vasculaires en général et des artères coronaires en particulier |
| US7901452B2 (en) * | 2007-06-27 | 2011-03-08 | Abbott Cardiovascular Systems Inc. | Method to fabricate a stent having selected morphology to reduce restenosis |
| US7955381B1 (en) | 2007-06-29 | 2011-06-07 | Advanced Cardiovascular Systems, Inc. | Polymer-bioceramic composite implantable medical device with different types of bioceramic particles |
| US20090035350A1 (en) | 2007-08-03 | 2009-02-05 | John Stankus | Polymers for implantable devices exhibiting shape-memory effects |
| US20090306120A1 (en) * | 2007-10-23 | 2009-12-10 | Florencia Lim | Terpolymers containing lactide and glycolide |
| US7972373B2 (en) * | 2007-12-19 | 2011-07-05 | Advanced Technologies And Regenerative Medicine, Llc | Balloon expandable bioabsorbable stent with a single stress concentration region interconnecting adjacent struts |
| US8057876B2 (en) * | 2008-02-25 | 2011-11-15 | Abbott Cardiovascular Systems Inc. | Bioabsorbable stent with layers having different degradation rates |
| US8206635B2 (en) | 2008-06-20 | 2012-06-26 | Amaranth Medical Pte. | Stent fabrication via tubular casting processes |
| US10898620B2 (en) | 2008-06-20 | 2021-01-26 | Razmodics Llc | Composite stent having multi-axial flexibility and method of manufacture thereof |
| US8206636B2 (en) | 2008-06-20 | 2012-06-26 | Amaranth Medical Pte. | Stent fabrication via tubular casting processes |
| WO2010138212A2 (en) * | 2009-05-29 | 2010-12-02 | Incube Labs, Llc | Biodegradable medical implants, polymer compositions and methods of use |
| EP2440162A1 (en) * | 2009-06-08 | 2012-04-18 | Boston Scientific Scimed, Inc. | Crosslinked bioabsorbable medical devices |
| CN102573655B (zh) * | 2009-06-17 | 2016-03-16 | 吉卢比有限公司 | 用于在体内和/或体外富集样本材料的探测装置 |
| US20110159072A1 (en) * | 2009-12-30 | 2011-06-30 | Surmodics, Inc. | Controlled release matrix |
| US9993441B2 (en) | 2009-12-30 | 2018-06-12 | Surmodics, Inc. | Controlled release matrix barrier structure for subcutaneous medical devices |
| US8808353B2 (en) | 2010-01-30 | 2014-08-19 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds having a low crossing profile |
| US8568471B2 (en) | 2010-01-30 | 2013-10-29 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds |
| KR101253284B1 (ko) * | 2011-04-14 | 2013-04-10 | 한국과학기술연구원 | 스텐트의 표면 개질 방법 |
| US10105246B2 (en) * | 2011-06-07 | 2018-10-23 | Qing Liu | Hybrid polymer stent fabricated by a non-laser cut fabrication method |
| US8726483B2 (en) | 2011-07-29 | 2014-05-20 | Abbott Cardiovascular Systems Inc. | Methods for uniform crimping and deployment of a polymer scaffold |
| EP2744447B1 (en) * | 2011-08-16 | 2018-10-10 | DePuy Synthes Products, LLC | Thermoplastic multilayer article |
| US20140330359A1 (en) | 2013-05-03 | 2014-11-06 | Amaranth Medical Pte. | Methods and apparatus for stent delivery and deployment |
| CN105658181B (zh) | 2013-08-16 | 2018-05-18 | 阿玛安斯医药私人公司 | 用于治疗交叉病变的可生物吸收骨架 |
| US9675478B2 (en) * | 2014-06-11 | 2017-06-13 | Abbott Cardiovascular Systems Inc. | Solvent method for forming a polymer scaffolding |
| US9259339B1 (en) | 2014-08-15 | 2016-02-16 | Elixir Medical Corporation | Biodegradable endoprostheses and methods of their fabrication |
| US9855156B2 (en) | 2014-08-15 | 2018-01-02 | Elixir Medical Corporation | Biodegradable endoprostheses and methods of their fabrication |
| US9480588B2 (en) | 2014-08-15 | 2016-11-01 | Elixir Medical Corporation | Biodegradable endoprostheses and methods of their fabrication |
| US9730819B2 (en) | 2014-08-15 | 2017-08-15 | Elixir Medical Corporation | Biodegradable endoprostheses and methods of their fabrication |
| CN104473706B (zh) * | 2014-12-09 | 2017-02-22 | 金华市人民医院 | 一种可降解的复合型管状尿道支架及制备方法 |
| US9999527B2 (en) | 2015-02-11 | 2018-06-19 | Abbott Cardiovascular Systems Inc. | Scaffolds having radiopaque markers |
| US9700443B2 (en) | 2015-06-12 | 2017-07-11 | Abbott Cardiovascular Systems Inc. | Methods for attaching a radiopaque marker to a scaffold |
| ES2873887T3 (es) | 2016-05-16 | 2021-11-04 | Elixir Medical Corp | Liberación de stent |
| US11622872B2 (en) | 2016-05-16 | 2023-04-11 | Elixir Medical Corporation | Uncaging stent |
| CA3079536A1 (en) * | 2016-10-18 | 2018-04-26 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Tuning adhesion at contacting device interfaces: geometric tools for minimizing surface fouling |
| WO2018107123A1 (en) | 2016-12-09 | 2018-06-14 | Zenflow, Inc. | Systems, devices, and methods for the accurate deployment of an implant in the prostatic urethra |
| WO2018181179A1 (ja) | 2017-03-30 | 2018-10-04 | テルモ株式会社 | 親水性部材と疎水性部材とを積層させた医療機器 |
| CN109172075A (zh) * | 2018-08-20 | 2019-01-11 | 南京永明医疗器械有限公司 | 一种含弹性层的全降解血管支架及其制备方法 |
| CN110960734B (zh) * | 2019-10-30 | 2022-04-22 | 上海七木医疗器械有限公司 | 一种可降解螺旋支架的制备方法 |
| JP2023502997A (ja) | 2019-11-19 | 2023-01-26 | ゼンフロー， インコーポレイテッド | 前立腺部尿道内のインプラントの正確な展開および撮像のためのシステム、デバイス、および方法 |
| CN111035809B (zh) * | 2019-12-04 | 2021-06-01 | 中山大学 | 一种具备三维形变结构的双层复合纳米纤维膜及其制备方法和应用 |
| CN112807059A (zh) * | 2021-02-26 | 2021-05-18 | 上海微创医疗器械（集团）有限公司 | 一种自膨式医用植入物及医用装置 |
Family Cites Families (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE445884B (sv) * | 1982-04-30 | 1986-07-28 | Medinvent Sa | Anordning for implantation av en rorformig protes |
| SE453258B (sv) * | 1986-04-21 | 1988-01-25 | Medinvent Sa | Elastisk, sjelvexpanderande protes samt forfarande for dess framstellning |
| JP2561853B2 (ja) * | 1988-01-28 | 1996-12-11 | 株式会社ジェイ・エム・エス | 形状記憶性を有する成形体及びその使用方法 |
| US5139480A (en) * | 1990-08-22 | 1992-08-18 | Biotech Laboratories, Inc. | Necking stents |
| US6248129B1 (en) * | 1990-09-14 | 2001-06-19 | Quanam Medical Corporation | Expandable polymeric stent with memory and delivery apparatus and method |
| US5258020A (en) * | 1990-09-14 | 1993-11-02 | Michael Froix | Method of using expandable polymeric stent with memory |
| US5163952A (en) * | 1990-09-14 | 1992-11-17 | Michael Froix | Expandable polymeric stent with memory and delivery apparatus and method |
| DE69333161T2 (de) * | 1992-05-08 | 2004-06-03 | Schneider (Usa) Inc., Plymouth | Stent für den Oesophagus |
| US5443458A (en) * | 1992-12-22 | 1995-08-22 | Advanced Cardiovascular Systems, Inc. | Multilayered biodegradable stent and method of manufacture |
| US5630840A (en) * | 1993-01-19 | 1997-05-20 | Schneider (Usa) Inc | Clad composite stent |
| EP0696185B1 (en) * | 1993-04-28 | 1998-08-12 | Focal, Inc. | Apparatus, product and use related to intraluminal photothermoforming |
| US5716410A (en) * | 1993-04-30 | 1998-02-10 | Scimed Life Systems, Inc. | Temporary stent and method of use |
| US5735892A (en) * | 1993-08-18 | 1998-04-07 | W. L. Gore & Associates, Inc. | Intraluminal stent graft |
| US5954744A (en) * | 1995-06-06 | 1999-09-21 | Quanam Medical Corporation | Intravascular stent |
| US5824332A (en) * | 1995-10-05 | 1998-10-20 | Jannetta; Peter J. | Method and apparatus for treatment of neurogenic diabetes mellitus, and other conditions |
| US6007573A (en) * | 1996-09-18 | 1999-12-28 | Microtherapeutics, Inc. | Intracranial stent and method of use |
| US6117168A (en) * | 1996-12-31 | 2000-09-12 | Scimed Life Systems, Inc. | Multilayer liquid absorption and deformation devices |
| US6245103B1 (en) * | 1997-08-01 | 2001-06-12 | Schneider (Usa) Inc | Bioabsorbable self-expanding stent |
| US5962007A (en) * | 1997-12-19 | 1999-10-05 | Indigo Medical, Inc. | Use of a multi-component coil medical construct |
| KR100382568B1 (ko) * | 1998-02-23 | 2003-05-09 | 메사츄세츠 인스티튜트 어브 테크놀로지 | 생물분해성 형상기억 중합체 |
| JP3732404B2 (ja) * | 1998-02-23 | 2006-01-05 | ニーモサイエンス ゲーエムベーハー | 形状記憶ポリマー組成物、形状記憶製品を形成する方法、および形状を記憶する組成物を形成する方法 |
| JP4889151B2 (ja) * | 1998-09-08 | 2012-03-07 | 株式会社 京都医療設計 | 脈管用ステント |
| US6547814B2 (en) * | 1998-09-30 | 2003-04-15 | Impra, Inc. | Selective adherence of stent-graft coverings |
| AU763085B2 (en) * | 1998-11-12 | 2003-07-10 | Takiron Co. Ltd. | Shape-memory, biodegradable and absorbable material |
| US6503270B1 (en) * | 1998-12-03 | 2003-01-07 | Medinol Ltd. | Serpentine coiled ladder stent |
| US6368346B1 (en) * | 1999-06-03 | 2002-04-09 | American Medical Systems, Inc. | Bioresorbable stent |
| US6364904B1 (en) * | 1999-07-02 | 2002-04-02 | Scimed Life Systems, Inc. | Helically formed stent/graft assembly |
| US6790228B2 (en) * | 1999-12-23 | 2004-09-14 | Advanced Cardiovascular Systems, Inc. | Coating for implantable devices and a method of forming the same |
| US6338739B1 (en) * | 1999-12-22 | 2002-01-15 | Ethicon, Inc. | Biodegradable stent |
| IL137090A (en) * | 2000-06-29 | 2010-04-15 | Pentech Medical Devices Ltd | Polymeric stent |
| US20020077693A1 (en) * | 2000-12-19 | 2002-06-20 | Barclay Bruce J. | Covered, coiled drug delivery stent and method |
| WO2002039948A2 (en) * | 2000-11-14 | 2002-05-23 | N.V.R. Labs Inc. | Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| US7087078B2 (en) * | 2000-11-21 | 2006-08-08 | Schering Ag | Tubular vascular implants (stents) and methods for producing the same |
| ATE406146T1 (de) * | 2000-11-22 | 2008-09-15 | Bard Peripheral Vascular Inc | Verfahren zur herstellung einer röhrenförmigen struktur aus expandiertem polytetrafluorethylen mit mikrowand hoher dichte |
| KR20030040203A (ko) * | 2001-05-11 | 2003-05-22 | 마쯔시다덴기산교 가부시키가이샤 | 부호화 장치, 복호화 장치 및 방송 시스템 |
| US20030069629A1 (en) * | 2001-06-01 | 2003-04-10 | Jadhav Balkrishna S. | Bioresorbable medical devices |
| US7008446B1 (en) * | 2001-08-17 | 2006-03-07 | James Peter Amis | Thermally pliable and carbon fiber stents |
| US7572287B2 (en) * | 2001-10-25 | 2009-08-11 | Boston Scientific Scimed, Inc. | Balloon expandable polymer stent with reduced elastic recoil |
| AU2003222660A1 (en) * | 2002-04-18 | 2003-11-03 | Robert S. Langer | Biodegradable shape memory polymeric sutures |
| DE10219014A1 (de) * | 2002-04-27 | 2003-11-13 | Ruesch Willy Gmbh | Selbstexpandierbarer Stent |
| US20030216804A1 (en) * | 2002-05-14 | 2003-11-20 | Debeer Nicholas C. | Shape memory polymer stent |
| US20040034405A1 (en) * | 2002-07-26 | 2004-02-19 | Dickson Andrew M. | Axially expanding polymer stent |
| EP1543860B1 (en) * | 2002-09-25 | 2015-02-18 | Kabushikikaisha Igaki Iryo Sekkei | Thread for vascular stent and vascular stent using the thread |
| US6770729B2 (en) * | 2002-09-30 | 2004-08-03 | Medtronic Minimed, Inc. | Polymer compositions containing bioactive agents and methods for their use |
| EP1554328B1 (en) * | 2002-10-11 | 2011-02-23 | The University of Connecticut | Shape memory polymers based on semicrystalline thermoplastic polyurethanes bearing nanostructured hard segments |
| US6932930B2 (en) * | 2003-03-10 | 2005-08-23 | Synecor, Llc | Intraluminal prostheses having polymeric material with selectively modified crystallinity and methods of making same |
| US20050010170A1 (en) * | 2004-02-11 | 2005-01-13 | Shanley John F | Implantable medical device with beneficial agent concentration gradient |
| AU2004246998A1 (en) * | 2003-06-16 | 2004-12-23 | Nanyang Technological University | Polymeric stent and method of manufacture |
| US20050100577A1 (en) * | 2003-11-10 | 2005-05-12 | Parker Theodore L. | Expandable medical device with beneficial agent matrix formed by a multi solvent system |
| US8192752B2 (en) * | 2003-11-21 | 2012-06-05 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable devices including biologically erodable polyesters and methods for fabricating the same |
| TW200604249A (en) * | 2004-03-24 | 2006-02-01 | Commw Scient Ind Res Org | Biodegradable polyurethane and polyurethane ureas |
| CN1960684B (zh) * | 2004-04-02 | 2013-11-06 | 动脉再塑技术公司 | 基于聚合物的支架装置 |
| US20060025852A1 (en) * | 2004-08-02 | 2006-02-02 | Armstrong Joseph R | Bioabsorbable self-expanding endolumenal devices |
| CA2577018C (en) * | 2004-08-13 | 2012-03-27 | Reva Medical, Inc. | Inherently radiopaque bioresorbable polymers for multiple uses |
| US8119153B2 (en) * | 2004-08-26 | 2012-02-21 | Boston Scientific Scimed, Inc. | Stents with drug eluting coatings |
| JP4149980B2 (ja) * | 2004-09-17 | 2008-09-17 | シャープ株式会社 | 半導体製造装置の製造方法 |
| US7901451B2 (en) * | 2004-09-24 | 2011-03-08 | Biosensors International Group, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
| US20070060895A1 (en) * | 2005-08-24 | 2007-03-15 | Sibbitt Wilmer L Jr | Vascular closure methods and apparatuses |
-
2004
- 2004-06-15 AU AU2004246998A patent/AU2004246998A1/en not_active Abandoned
- 2004-06-15 US US10/867,617 patent/US20050021131A1/en not_active Abandoned
- 2004-06-15 CN CNB2004800169315A patent/CN100558321C/zh not_active Expired - Lifetime
- 2004-06-15 WO PCT/SG2004/000180 patent/WO2004110315A1/en active Application Filing
- 2004-06-15 EP EP04736895A patent/EP1633280A4/en not_active Withdrawn
- 2004-06-15 CA CA002529494A patent/CA2529494A1/en not_active Abandoned
- 2004-06-15 BR BRPI0411548-1A patent/BRPI0411548A/pt not_active Application Discontinuation
- 2004-06-15 KR KR1020057024110A patent/KR20060028695A/ko not_active Application Discontinuation
- 2004-06-15 JP JP2006517067A patent/JP2006527628A/ja not_active Withdrawn
-
2008
- 2008-04-24 US US12/109,317 patent/US20080208321A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006527628A (ja) | 2006-12-07 |
| EP1633280A1 (en) | 2006-03-15 |
| US20080208321A1 (en) | 2008-08-28 |
| AU2004246998A1 (en) | 2004-12-23 |
| CN1812754A (zh) | 2006-08-02 |
| US20050021131A1 (en) | 2005-01-27 |
| WO2004110315A1 (en) | 2004-12-23 |
| BRPI0411548A (pt) | 2006-08-01 |
| EP1633280A4 (en) | 2011-03-16 |
| KR20060028695A (ko) | 2006-03-31 |
| CN100558321C (zh) | 2009-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20050021131A1 (en) | Polymeric stent and method of manufacture | |
| US8303650B2 (en) | Biodegradable self-expanding drug-eluting prosthesis | |
| US8317857B2 (en) | Biodegradable self-expanding prosthesis | |
| JP5632401B2 (ja) | 一時的な管腔内ステント、並びにそれを作製及び使用する方法 | |
| EP3384878B1 (en) | A method of making a self-expanding implant | |
| US20150081000A1 (en) | Braided scaffolds | |
| US20080167710A1 (en) | Medical Device Having Regions With Various Agents Dispersed Therein and a Method for Making the Same | |
| US20200229954A1 (en) | Bioabsorbable flow diverting scaffold | |
| JP2006262960A (ja) | ステント | |
| AU2011265474B2 (en) | Temporal intraluminal stent, methods of making and using | |
| JP2007089917A (ja) | 生体内留置物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |